{{Rsnum
|rsid=9261129
|Gene=NCRNA00171
|Chromosome=6
|position=30011802
|Orientation=plus
|GMAF=0.1846
|Gene_s=HCG8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 2.2 | 35.0 | 62.8
| JPT | 8.9 | 44.6 | 46.4
| YRI | 6.9 | 48.3 | 44.8
| ASW | 3.5 | 52.6 | 43.9
| CHB | 2.2 | 35.0 | 62.8
| CHD | 4.6 | 19.3 | 76.1
| GIH | 2.0 | 19.8 | 78.2
| LWK | 6.4 | 42.7 | 50.9
| MEX | 8.6 | 39.7 | 51.7
| MKK | 5.1 | 41.0 | 53.8
| TSI | 1.0 | 35.3 | 63.7
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs9261129
|Name_s=
|Gene_s=HLA-J, HCP5P2, HCG4P3
|Feature=
|Evidence=PubMed ID:17641165
|Annotation=This variant is associated with low HIV viral load and disease progression.
|Drugs=
|Drug Classes=
|Diseases=HIV; HIV Infections
|Curation Level=Curated
|PharmGKB Accession ID=PA162316700
}}

{{PMID Auto
|PMID=18495769
|Title=Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
|OA=1
}}

{{PMID Auto
|PMID=18982067
|Title=HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
|OA=1
}}

{{PMID Auto
|PMID=20041166
|Title=Common genetic variation and the control of HIV-1 in humans.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9261129
|overall_frequency_n=25
|overall_frequency_d=128
|overall_frequency=0.195312
|n_genomes=24
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}